Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • harvard1
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
ACTG2 Inhibits Growth and Is Epigenetically Repressed in Small Intestinal Neuroendocrine Tumors
Uppsala universitet, Endokrinkirurgi.ORCID iD: 0000-0001-7366-6258
Uppsala universitet, Endokrinkirurgi.
Uppsala universitet, Endokrinkirurgi.
Uppsala universitet, Endokrinkirurgi.
2014 (English)In: Neuroendocrinology, ISSN 0028-3835, E-ISSN 1423-0194, Vol. 99, no 3-4, 227-227 p.Article in journal (Other academic) Published
Place, publisher, year, edition, pages
2014. Vol. 99, no 3-4, 227-227 p.
Keyword [en]
si-net, actg2, mir-145, epigenetics
National Category
Endocrinology and Diabetes
Identifiers
URN: urn:nbn:se:rkh:diva-1475DOI: 10.1159/000367792OAI: oai:DiVA.org:rkh-1475DiVA: diva2:794238
Conference
11th Annual ENETS Conference for the Diagnosis and Treatment of Neuroendocrine Tumor Disease, MAR 05-07, 2014, Barcelona, SPAIN
Available from: 2014-12-10 Created: 2015-03-10 Last updated: 2015-03-11Bibliographically approved

Open Access in DiVA

No full text

Other links

Publisher's full text

Search in DiVA

By author/editor
Edfeldt, Katarina
In the same journal
Neuroendocrinology
Endocrinology and Diabetes

Search outside of DiVA

GoogleGoogle Scholar

Altmetric score

Total: 58 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • harvard1
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf